Advancements in Real-Time Data Processing in Medical Research

Authors

  • Naveen Kumar Pedada Osmania University, India Author

DOI:

https://doi.org/10.32628/CSEIT25112734

Keywords:

Real-time data processing, clinical trials, artificial intelligence, medical breakthroughs, global health equity

Abstract

Real-time data processing has revolutionized medical research by transforming how clinical investigations are conducted and analyzed. This article examines the evolution from traditional batch processing to instantaneous data analysis across the healthcare ecosystem. The article explores five key areas: the historical context and transformative potential of real-time processing; its application in clinical trials through electronic data capture and risk-based monitoring; artificial intelligence applications in drug discovery that have dramatically accelerated therapeutic development; breakthrough treatments enabled by continuous monitoring technologies; and global health implications with focus on infectious disease management and health equity. Ethical considerations, privacy concerns, and implementation challenges in resource-limited settings are also addressed, along with emerging technologies that promise to transform biomedical research and clinical practice further. The integration of real-time data processing represents a paradigm shift with profound implications for patient outcomes, healthcare resource allocation, and global disease eradication efforts.

Downloads

Download data is not yet available.

References

Jonathan H. Chen et al., "Machine Learning and Prediction in Medicine — Beyond the Peak of Inflated Expectations," N Engl J Med, VOL. 376 NO. 26, 2017. https://www.nejm.org/doi/full/10.1056/NEJMp1702071

Joseph A DiMasi et al., "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, vol. 47, pp. 20–33, 2016. https://www.sciencedirect.com/science/article/abs/pii/S0167629616000291

Kimberly A Mc Cord et al., "Using electronic health records for clinical trials: Where do we stand and where can we go?," 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6351244/

Simbec-Orion, "Remote Monitoring in Clinical Trials: The Benefits and Challenges," 2024. https://www.simbecorion.com/remote-monitoring-clinical-trials/

Jianyuan Den et al., "Artificial intelligence in drug discovery: applications and techniques," Briefings in Bioinformatics, Volume 23, Issue 1, January 2022, bbab430, 2021. https://academic.oup.com/bib/article/23/1/bbab430/6420092

Andrew Anighoro, "Deep learning in structure-based drug design," 2022. https://pubmed.ncbi.nlm.nih.gov/34731473/

Peter M Rothwell, “External validity of randomized controlled trials: "to whom do the results of this trial apply”?" 2005. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(04)17670-8/abstract

Laura H. Goetz M.D, Nicholas J. Schork Ph.D, "Personalized medicine: motivation, challenges, and progress," 2005. https://www.sciencedirect.com/science/article/pii/S0015028218304072

World Health Organization, "Global Strategy on Digital Health 2020-2025," 2021. https://www.who.int/publications/i/item/9789240020924

John S Rumsfeld et al., "Big data analytics to improve cardiovascular care: promise and challenges," 2016. https://pubmed.ncbi.nlm.nih.gov/27009423/

Sarah Myers West, "Discriminating Systems: Gender, Race, and Power in AI," AI Now Institute, New York University, 2019. https://ainowinstitute.org/publication/discriminating-systems-gender-race-and-power-in-ai-2

Downloads

Published

19-03-2025

Issue

Section

Research Articles